Notable Analyst Rating Changes 03/10: ITMN, RDN, EIX, IFSIA Upgraded; FACT, VALE, PSS, NLY, AVAV Downgraded Mar 10, 2010 10:45AM
Merriman Curhan Ford Downgrades Facet Biotech (FACT) to Neutral; Acquisition Price is Full & Fair Mar 10, 2010 07:04AM
Merriman Curhan Ford Top Picks for 2010: CELG, FACT, CSTR, TASR, more... Jan 5, 2010 03:22PM
Biogen (BIIB) Must Raise Offer for Facet (FACT) to At Least $22/Share -Merriman Dec 16, 2009 01:19PM
Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer Oct 1, 2009 01:34PM


Sep 28, 2009 10:19AM Notable Analyst Rating Changes 9/28: CSCO, VPHM, ACN, AMAT, GD Upgraded; RBS, WFR, ISRG, WXS Downgraded
Sep 28, 2009 07:26AM Merriman Curhan Ford Initiates Coverage on Facet Biotech (FACT) with a Buy